Algorae Pharmaceuticals – Updated Securities Trading Policy ASX: 1AI | 28 October 2026 Algorae Pharmaceuticals Limited (ASX: 1AI) (‘Algorae’ or ‘the Company’) provides the attached updated Securities Trading Policy in accordance with ASX Listing Rule 12.10. A copy of the Securities...
Updated Securities Trading Policy
Filed with ASX · · 12 pages · English
Summary by 6ix AI
Algorae Pharmaceuticals Limited has released an updated Securities Trading Policy to comply with ASX Listing Rules. The policy outlines the rules regarding dealings in the company's securities by directors, employees, and contractors, including restrictions during blackout periods. It aims to ensure compliance with insider trading laws and protect the company's reputation. The announcement has been approved by the Board of Directors and is available on the company's website.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Algorae Pharmaceuticals Limited on 6ix
In the deck
Earlier from Algorae Pharmaceuticals
- Algorae executes Licence & Supply Agreement with Umedica
- Peter Mac partners with Algorae on 3rd AI validation program
- Notice of Annual General Meeting/Proxy Form
- Change of Director's Interest Notice - DH
- Date of AGM and Closing Date for Director Nominations
Later from Algorae Pharmaceuticals
All Algorae Pharmaceuticals news releasesFollow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals